title: Basal forebrain neurons suppress amygdala kindling via cortical but not hippocampal cholinergic projections in rats.
abstract: Intraventricular administration of the immunotoxin 192 IgG-saporin in rats has been shown to cause a selective loss of cholinergic afferents to the hippocampus and cortical areas, and to facilitate seizure development in hippocampal kindling. Here we demonstrate that this lesion also accelerates seizure progression when kindling is induced by electrical stimulations in the amygdala. However, whereas intraventricular 192 IgG-saporin facilitated the development of the initial stages of hippocampal kindling, the same lesion promoted the late stages of amygdala kindling. To explore the role of various parts of the basal forebrain cholinergic system in amygdala kindling, selective lesions of the cholinergic projections to either hippocampus or cortex were produced by intraparenchymal injections of 192 IgG-saporin into medial septum/vertical limb of the diagonal band or nucleus basalis, respectively. Cholinergic denervation of the cortical regions caused acceleration of amygdala kindling closely resembling that observed after the more widespread lesion induced by intraventricular 192 IgG-saporin. In contrast, removal of the cholinergic input to the hippocampus had no effect on the development of amygdala kindling. These data indicate that basal forebrain cholinergic neurons suppress kindling elicited from amygdala, and that this dampening effect is mediated via cortical but not hippocampal projections.
authors.affiliation: Section of Restorative Neurology, Wallenberg Neuroscience Center, University Hospital, S-221 85 Lund, Sweden. istvan.ferencz@neurol.lu.se
authors.forename: I
authors.initials: I
authors.lastname: Ferencz
authors.forename: G
authors.initials: G
authors.lastname: Leanza
authors.forename: A
authors.initials: A
authors.lastname: Nanobashvili
authors.forename: M
authors.initials: M
authors.lastname: Kokaia
authors.forename: O
authors.initials: O
authors.lastname: Lindvall
mesh_terms: D000679:Amygdala / Q000166:cytology* / Q000502:physiology*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D020532:Basal Nucleus of Meynert / Q000166:cytology*; D018678:Cholinergic Agents / Q000494:pharmacology; D002799:Cholinergic Fibers / Q000502:physiology; D004827:Epilepsy / Q000503:physiopathology; D006624:Hippocampus / Q000166:cytology*; D000922:Immunotoxins / Q000494:pharmacology; D007276:Injections, Intraventricular; D007696:Kindling, Neurologic / Q000502:physiology*; D008297:Male; D009699:N-Glycosyl Hydrolases; D009434:Neural Pathways; D009474:Neurons / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins; D012686:Septal Nuclei / Q000166:cytology
chemical_list: C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D000922:Immunotoxins; D054789:Ribosome Inactivating Proteins, Type 1; D009699:N-Glycosyl Hydrolases; D000076985:Saporins